Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Multimodal Therapy of Upper Gastrointestinal Malignancies
| Multimodal Therapy of Upper Gastrointestinal Malignancies |
| Autore | Ronellenfitsch Ulrich |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (272 p.) |
| Soggetto topico | Public health and preventive medicine |
| Soggetto non controllato |
adjuvant therapy
Barrett's esophagus cancer dormancy chemo-radiotherapy clinical pathways complications conversion surgery definitive chemoradiotherapy early adenocarcinoma of esophagus endoscopic mucosal resection endoscopic submucosal dissection esophageal anastomosis esophageal cancer esophageal squamous cell carcinoma esophagectomy failure to rescue gastrectomy gastric cancer gastric surgery gastric/gastroesophageal cancer gastro-esophageal reflux disease gastrointestinal stromal tumor gastrointestinal tract genetic diagnosis genetics GIST imatinib immunotherapy induction chemotherapy Lauren histotype lymph node ratio MALT lymphoma minimally invasive surgery mortality mucosal resection multidisciplinary multimodal treatment n/a neoadjuvant chemoradiotherapy neoadjuvant chemotherapy neoadjuvant therapy neoadjuvant treatment neuroendocrine tumor nuclear receptor NR2F1 nutritional status oncological gastrectomy organ preservation outcome outcomes overall survival perioperative chemotherapy quality of care radiosensitivity relapse-free survival sarcopenia skeletal muscle index squamous cell esophageal cancer standardization stomach submucosal dissection survival |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557781603321 |
Ronellenfitsch Ulrich
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Small Cell Lung Cancer: A New Era Is Beginning?
| Small Cell Lung Cancer: A New Era Is Beginning? |
| Autore | Morabito Alessandro |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (150 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
atezolizumab
biology of SCLC chemotherapy circulating tumor cells DDR durvalumab extensive disease extensive-stage small cell lung cancer gene pathway ICB immune checkpoint inhibitors immune-checkpoint inhibitors in SCLC immunotherapy Immunotherapy ipilimumab lobectomy lurbinectedin multimodal treatment n/a nivolumab PARP pathobiology pathology and classification of SCLC pembrolizumab pneumonectomy prognostic biomarker radiotherapy SCLC SLFN11 small cell lung cancer small-cell lung cancer STING synthetic lethality targeted agents targeted therapy |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Small Cell Lung Cancer |
| Record Nr. | UNINA-9910557380603321 |
|
Morabito Alessandro
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||